Similarly, hypermethylation of SHISA3, KCNA3, NPY, and hypomethylation of NUMB, BST2, MAPK13 promoters, which have previously been implicated in other cancers, robustly separate normal and GBC-OSCC samples (Fig. 1). This evidence concerns the gene BST2 and cancer.